Intranasal (IN) administration of oximes was found to effectively bypass the BBB.
IN obidoxime (OBD) partially restored brain AChE activity after paraoxon poisoning.
IN OBD dramatically reduced paraoxon-induced seizures.
IN OBD fully prevented all neuronal cell loss associated with paraoxon poisoning.
IN OBD completely prevented the mortality associated with paraoxon poisoning.